This clinical trial evaluates whether guided meditation during radiation therapy treatments reduces anxiety in patients undergoing radiation for a brain tumor. Anxiety and distress are well-known symptoms in patients with cancer undergoing treatment. These symptoms are particularly prominent in patients undergoing radiation therapy to the brain or head and neck region, as these treatments require the use of a mask that immobilizes the head. Mindfulness-based interventions have been shown to be helpful in reducing stress, depression and physical symptoms in cancer patients. In this study, patients participate in short audio-recorded mindfulness exercises, including body scan, mindful breathing, mindfulness of discomfort, savoring, and loving-kindness practices while undergoing their radiation treatments. Meditation during radiation therapy may work to reduce feelings of anxiety in patients undergoing treatment for a brain tumor.
Additional locations may be listed on ClinicalTrials.gov for NCT06165653.
Locations matching your search criteria
United States
Utah
Salt Lake City
Huntsman Cancer Institute/University of UtahStatus: Active
Contact: Lindsay M. Burt
Phone: 801-585-0255
PRIMARY OBJECTIVE:
I. To assess the acute anxiolytic effects of a brief mindfulness intervention during radiation therapy (RT) for brain tumor patients with mask anxiety.
SECONDARY OBJECTIVES:
I. To assess the distal anxiolytic effects of a brief mindfulness intervention during RT for brain tumor patients with mask anxiety.
II. To determine whether the brief mindfulness intervention during RT increases brain tumor patients’ state mindfulness and whether the degree of changes in state mindfulness during RT predict decreases in acute anxiety and anxiety in daily life.
III. To determine whether the brief mindfulness intervention during RT increases brain tumor patients’ self transcendence and whether the degree of changes in self transcendence during RT predict decreases in anxiety in daily life.
EXPLORATORY OBJECTIVE:
I. To explore the possibility of cognitive factors predicting treatment/intervention effect.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM 1: Patients participate in guided meditation over 5 minutes during each of their standard of care (SOC) radiation treatments 5 days a week for 5-7 weeks.
ARM 2: Patients receive the standard of care during each of their SOC radiation treatments 5 days a week for 5-7 weeks.
After completion of study intervention, patients are followed up at 90 days.
Trial PhaseNo phase specified
Trial Typetreatment
Lead OrganizationHuntsman Cancer Institute/University of Utah
Principal InvestigatorLindsay M. Burt
